Birkbeck, University of London Featured PhD Programmes
The Francis Crick Institute Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Imperial College London Featured PhD Programmes
The Hong Kong Polytechnic University Featured PhD Programmes
"drug" AND "delivery" AND…×
10 miles

drug delivery system PhD Projects, Programs & Scholarships

We have 14 drug delivery system PhD Projects, Programs & Scholarships

  • "drug" AND "delivery" AND "system" ×
  • clear all
Order by 
Showing 1 to 10 of 14
  Iontophoresis to deliver corticosteroids across buccal mucosal using hydrogel as delivery systems
  Prof M Patel, Dr E Hagi-Pavli
Applications accepted all year round

Funding Type

PhD Type

Background. Topical delivery of drugs to treat oral mucosal disease is often challenging. This is due to, for example, the saliva washing therapeutic agents away into the gastrointestinal system, the movement of oral structures during mastication and the presence of keratinized oral mucosal surfaces.
  Development of transdermal protein liposomal delivery system for the treatment of dermatological diseases
  Research Group: Chemistry and Biosciences
  Dr M Najafzadeh, Prof D Anderson
Applications accepted all year round

Funding Type

PhD Type

Biopharmaceuticals have been increasingly used in the treatment of skin diseases. However, due to the poor absorption of peptide and protein through the skin, they are usually delivered through injections.
  Nanotechnologies for cancer: developing new polymer-drug conjugates for the treatment of a range of cancers
  Dr F Greco, Prof H Osborn
Applications accepted all year round

Funding Type

PhD Type

Polymer anticancer-drug conjugates are drug delivery systems in which a low molecular weight anticancer agent is covalently conjugated to a water-soluble polymeric carrier.
  Epigenetic therapy using ultrasound-mediated microbubble drug delivery for cancer treatment
  Dr E Valleley, Dr L Coletta
Applications accepted all year round

Funding Type

PhD Type

The project is an interdisciplinary, pre-clinical study that aims to investigate the response of human tumour cells to treatment with epigenetic inhibitors (such as DNA methyltransferase inhibitors), as a potential combination therapy for colorectal cancer (CRC).
  Analysing the factors that regulate expression of blood-brain barrier drug transporter proteins
  Dr J L Penny, Dr C Demonacos
Applications accepted all year round

Funding Type

PhD Type

In order to treat diseases associated with the central nervous system (CNS), e.g. cancer, Parkinson’s disease, depression, it is essential for therapeutic drugs to be able to penetrate into the brain.
  Engineering nanomaterials for intracellular delivery in regenerative medicine.
  Dr C Chiappini, Prof F Dazzi
Application Deadline: 11 November 2019

Funding Type

PhD Type

This position is to conduct an ERC-funded research project. This exciting project aims to investigate the mechanisms activated by the interaction of cells with nanomaterials and leverage them to control the intracellular fate of the cargo.
  “Smart” scaffolds for preventing post-surgery infections and evaluation in a simulated in vivo microenvironment
  Dr A Anastasiou
Applications accepted all year round

Funding Type

PhD Type

Infections associated with bacterial colonisation around implants and scaffolds is a significant clinical problem both in orthopaedics and regenerative dentistry.
  GW4 BioMed MRC DTP PhD studentship: Inhibition of signaling pathways as a novel strategy to block antibiotic resistance
  Dr S Gebhard
Application Deadline: 25 November 2019

Funding Type

PhD Type

This project is one of a number that are in competition for funding from the ‘GW4 BioMed MRC Doctoral Training Partnership’ which is offering up to 18 studentships for entry in September 2020.
  Bacterial-derived magnetosomes as nanocarriers for cancer-killing oncolytic viruses.
  Dr M Muthana, Dr F Howard
Applications accepted all year round

Funding Type

PhD Type

Dysfunctional cellular processes that are the markers of neoplasms provide the ideal environment for viral infection including sustained proliferation and resistance to cell death.
  Non coding RNAs in Adrenocortical Cancer
  Prof G. Hutvagner
Applications accepted all year round

Funding Type

PhD Type

Background. Industry, society or clinical need for project and scientific rationale. Adrenocortical carcinoma (ACC) is a rare disease which occurs with an annual incidence of 2-4 cases per million with a five-year survival of less than 16-38%.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.